Company: TBPH
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001104659-25-033819
Chunk: 70

Company: Theravance Biopharma, Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 70
---
 International LP, EMAI Management, LLC, Madison Avenue GP, LLC, Caraway Jackson Investments LLC, and Eli Samaha. Madison Partners, Madison Avenue International LP, EMAI Management, LLC, Madison Avenue GP, LLC, Caraway Jackson Investments LLC, and Eli Samaha each has shared voting and dispositive power of 9,511,150 shares. As of November 14, 2024, Madison Avenue International LP beneficially owned 9,511,150 shares. Madison Partners and Madison Avenue GP, LLC, as the investment manager and general partner of Madison Avenue International LP, respectively, may be deemed to be the beneficial owner of the shares owned directly by Madison Avenue International LP. EMAI Management, LLC, as the general partner of Madison Partners, may be deemed to be the beneficial owner of the shares owned directly by Madison Avenue International LP. Caraway Jackson Investments LLC, as the owner of Madison Avenue GP, LLC, may be deemed to be the beneficial owner of the shares owned directly by Madison Avenue International LP. Mr. Samaha, as the non-member manager of Madison Avenue GP, LLC, the managing member of EMAI Management, LLC, and the majority owner of Caraway Jackson Investments LLC, may be deemed to be the beneficial owner of the shares owned by Madison Avenue International LP. (3) Based on the Amendment No. 2 to Schedule 13D filed with the SEC on March 5, 2024 by Weiss Asset Management LP, BIP GP LLC, WAM GP LLC and Andrew M. Weiss, Ph.D. Weiss Asset Management LP has shared voting and dispositive power over 7,457,060 shares. BIP GP LLC has shared voting and dispositive power over 4,628,074 shares. WAM GP LLC has shared voting and dispositive power over 7,457,060 shares. Dr. Weiss has shared voting and dispositive power over 7,457,060 shares. (4) Based on the Amendment No. 1 to Schedule 13G filed with the SEC on February 14, 2025 by Newtyn Management, LLC (“Newtyn Management”) and Newtyn TE Partners, LP. (“NTE”). Newtyn Management is the investment manager to NTE and Newtyn Partners, LP (“NP”). As of December 31, 2024, NTE held 2,902,002 shares, and NP held 1,855,401 shares. Newtyn Management,